about
Autofluorescence of the cells in human subretinal fluid.Clinical application of autofluorescence densitometry with a scanning laser ophthalmoscope.Photopigments in central serous chorioretinopathy.Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy.Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration.Fundus autofluorescence and optical coherence tomography findings in branch retinal vein occlusionCHOROIDAL MORPHOLOGY IN A PATIENT WITH HELLP SYNDROME.Morphologic changes of the fovea and visual acuity associated with retinal detachment secondary to circumscribed choroidal hemangiomaA Multicenter Randomized Controlled Study of Antioxidant Supplementation with Lutein for Chronic Central Serous Chorioretinopathy.The Contribution of Genetic Architecture to the 10-Year Incidence of Age-Related Macular Degeneration in the Fellow Eye.Seasonal Variation in the Incidence of Late-onset Bleb-related Infection After Filtering Surgery in Japan: The Japan Glaucoma Society Survey of Bleb-related Infection Report 3.Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration.Complement factor H R1210C among Japanese patients with age-related macular degeneration.A genome-wide association study identified a novel genetic loci STON1-GTF2A1L/LHCGR/FSHR for bilaterality of neovascular age-related macular degeneration.Retinal pigment epithelium tear after intravitreal aflibercept injection.A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.Mutation analysis of BEST1 in Japanese patients with Best's vitelliform macular dystrophy.Bilateral Serous Retinal Detachment Associated with Inferior Posterior Staphyloma Treated with Scleral Shortening and Vitrectomy.Treatment with sodium hyaluronate eye drops in a patient who had early-onset bleb leakage after trabeculectomy with mitomycin CInfrared fundus autofluorescence and central serous chorioretinopathy.Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4.Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy.Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry.Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.SUBFOVEAL CHOROIDAL THICKNESS IN PAPILLITIS TYPE OF VOGT-KOYANAGI-HARADA DISEASE AND IDIOPATHIC OPTIC NEURITIS.One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study.Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.Long-term observation of fundus infrared fluorescence after indocyanine green-assisted vitrectomy.Application of CASIA SS-1000 Optical Coherence Tomography Tear Meniscus Imaging in Testing the Efficacy of New Strip Meniscometry in Dry Eye Diagnosis.CHOROIDAL THICKNESS CHANGES IN ACUTE ZONAL OCCULT OUTER RETINOPATHY.Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography.CLINICAL CHARACTERISTICS OF IDIOPATHIC FOVEOMACULAR RETINOSCHISIS.Reply: To PMID 25555799.Meibomian gland loss due to trabeculectomy.Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumab.
P50
Q31031883-0A3F33B2-B997-435F-B868-BA3337BD4864Q33404314-F78B0F2B-1DAF-4DFF-8627-C96CC268D7E0Q33860654-26F5AEB5-F92C-48FF-8E18-4CCD122EA01DQ34585510-BB94CDB8-5D0D-42E0-BD99-19734EF18FFEQ36265220-2490E55F-3E87-4394-B437-02AD019798A3Q36415428-2069E17B-ABAA-423C-8FA8-48E15C31C147Q36930401-4934BF84-1969-4C9A-AC6B-8D0650EE3E3BQ37163436-84361ACA-6BD6-4478-9C10-BC01B815BB63Q38760315-A9198AFD-E926-4D4E-B9F7-32DC65C5F744Q38974196-97A2BAA1-AF30-4AA9-B922-1952D4649C1CQ40341769-BC96D632-CC84-41AE-B8DA-7C0A5AECDB5BQ40569047-98336C41-0451-4061-B060-689907CD4631Q40691418-3D5A0838-2878-47D8-8850-0A9B47DB0C11Q41242933-F5AB2942-02BE-4A5F-BD34-8137AA10381AQ41316525-1228E779-9AFD-4B16-BDB3-C9D9B936970DQ41504310-1B8A1EFC-C66D-431F-9D2F-1449FD931C82Q41558542-61E8A0AC-6779-4FCA-884A-7DBF3F198269Q41814897-FF8C820E-3825-4D43-96B9-6430A88BB4F6Q41970555-13253E8F-B1A0-44D1-A1D7-E6387FB4694FQ43077096-7E0EB9EE-6137-48DB-8108-E3C0E2B011D6Q43375899-6DC50D1E-9516-4BB0-BB76-B708CA5B3435Q43894667-A8FD7C5D-0C09-4667-A3CC-4F5ED7B2E6D2Q46429266-BEAB8158-B0D6-4712-9E9D-0F95F7DF7CE4Q47936014-64A296AF-85E1-4784-87F7-8E2A9CCF083BQ50240375-6E41E822-8C69-48F8-A54F-77C7F3FDE44CQ50266443-D02E1B34-E784-41D0-9914-7CC96B70C0D9Q50282573-56ED5753-14EC-4FEE-B427-D127D17D37B5Q50437971-8852B555-C393-4C6D-B587-9F3DBBFF483DQ50442114-0A3CB8DC-4532-4B2B-8832-B08E8A0D021EQ50513432-02D6B680-79D2-4D17-97B3-AEC519B43ABBQ50522887-9C61CE41-B2D3-4575-B407-84FF2E057D9FQ50697887-ED531A9B-1895-427C-8777-17A349E37F57Q50896331-FD9B1EB3-50B8-4972-8202-E98284C1296FQ52775910-F133C27B-9B52-40FF-91F6-396C6B0DCA6DQ53083424-C5609F75-095E-4097-91DA-1E601C1A501BQ53212835-5026D396-3DC2-4A90-845D-1AA445BC9B28Q53475241-13EF6FCB-8B87-44CD-863D-286B22094A40Q53544019-DD9C3086-CC0D-45E8-BCBD-309389C2BB8DQ54247660-7C2ADD71-773D-4651-9225-7CA1692678C1Q54333965-BEA38523-E4A6-4294-88D8-29C81789C285
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Tetsuju Sekiryu
@en
Tetsuju Sekiryu
@nl
type
label
Tetsuju Sekiryu
@en
Tetsuju Sekiryu
@nl
prefLabel
Tetsuju Sekiryu
@en
Tetsuju Sekiryu
@nl
P31
P496
0000-0001-8042-2729